New Role for DCR-1/Dicer in Caenorhabditis elegans Innate Immunity against the Highly Virulent Bacterium Bacillus thuringiensis DB27 by Iatsenko, I. et al.
New Role for DCR-1/Dicer in Caenorhabditis elegans Innate Immunity
against the Highly Virulent Bacterium Bacillus thuringiensis DB27
Igor Iatsenko, Amit Sinha, Christian Rödelsperger, Ralf J. Sommer
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Bacillus thuringiensis produces toxins that target invertebrates, including Caenorhabditis elegans. Virulence of Bacillus strains
is often highly specific, such that B. thuringiensis strain DB27 is highly pathogenic to C. elegans but shows no virulence for an-
other model nematode, Pristionchus pacificus. To uncover the underlying mechanisms of the differential responses of the two
nematodes to B. thuringiensisDB27 and to reveal the C. elegans defense mechanisms against this pathogen, we conducted a ge-
netic screen for C. elegansmutants resistant to B. thuringiensisDB27. Here, we describe a B. thuringiensisDB27-resistant C. el-
egansmutant that is identical to nasp-1, which encodes the C. elegans homolog of the nuclear-autoantigenic-sperm protein.
Gene expression analysis indicated a substantial overlap between the genes downregulated in the nasp-1mutant and targets of C.
elegans dcr-1/Dicer, suggesting that dcr-1 is repressed in nasp-1mutants, which was confirmed by quantitative PCR. Consistent
with this, the nasp-1mutant exhibits RNA interference (RNAi) deficiency and reduced longevity similar to those of a dcr-1mu-
tant. Building on these surprising findings, we further explored a potential role for dcr-1 in C. elegans innate immunity. We show
that dcr-1mutant alleles deficient in microRNA (miRNA) processing, but not those deficient only in RNAi, are resistant to B.
thuringiensisDB27. Furthermore, dcr-1 overexpression rescues the nasp-1mutant’s resistance, suggesting that repression of
dcr-1 determines the nasp-1mutant’s resistance. Additionally, we identified the collagen-encoding gene col-92 as one of the
downstream effectors of nasp-1 that play an important role in resistance to DB27. Taken together, these results uncover a previ-
ously unknown role for DCR-1/Dicer in C. elegans antibacterial immunity that is largely associated with miRNA processing.
Genetically tractable model organisms, including the nema-tode Caenorhabditis elegans, have provided detailed insights
into the origin and fundamental principles of immunity. More
than a decade of research on C. elegans has yielded a wealth of
knowledge about its innate immune response to various patho-
gens, uncovering multiple signaling pathways critical to C. elegans
survival after exposure to pathogens (for reviews, see references 1
to 7). Once activated, these pathways induce the expression of an
array of antimicrobial effectors that differ, depending on the
pathogen present (8–11). A variety of microbes, including bacteria
(12), fungi (13), viruses (14), and microsporidia (15), have been
used in C. elegans infection studies, with the main focus on etio-
logical agents of human diseases. In some cases, work onC. elegans
has led to the identification of conserved virulence factors of hu-
man pathogens (16, 17).
Among the natural pathogens ofC. elegans,Bacillus thuringien-
sis has been extensively studied and B. thuringiensis likely coexists
and coevolves with its host in the natural environment (18). B.
thuringiensis produces a variety of pore-forming toxins (PFTs),
called Cry toxins, that target the intestinal cells of insects (19) and
nematodes (20). The ability of some Cry toxins to target C. elegans
has been exploited to use this nematode as an in vivo system for
studying PFTs (21), and several C. elegans defense mechanisms
against PFTs have been discovered (22–27).
Although the C. elegans model has provided invaluable insight
into the immune defense against pathogens, a comparative ap-
proach with other nematodes would enhance our understanding
of the host response to pathogens. One nematode that has been
used extensively for comparative studies with C. elegans is Pris-
tionchus pacificus. In contrast to C. elegans, which is often found
on compost heaps and rotten fruit (28), P. pacificus is found in
tight association with scarab beetles (29). Not surprisingly, there-
fore, these two nematodes show different resistance patterns
(30–32) and transcriptional responses to pathogens (11). For ex-
ample, C. elegans dies when fed the human opportunistic bacteria
Pseudomonas aeruginosa and Staphylococcus aureus and B. thurin-
giensisCry5B toxin, whereasP. pacificus is resistant (20, 30). More-
over, we have previously shown (31) that out of 768 naturally
isolated Bacillus strains, only 20 were pathogenic and show dis-
tinct patterns of virulence for C. elegans and P. pacificus. The most
extreme difference was seen with regard to B. thuringiensis strain
DB27. DB27 kills C. elegans in less than 24 h, representing one of
the fastest killers of C. elegans known to date, whereas P. pacificus
is resistant to this bacterial strain (31). Our previous study (31)
also indicated that the determinants of B. thuringiensis DB27 vir-
ulence for C. elegans and also the mechanisms of C. elegans resis-
tance to this pathogen are unknown. Specifically, we have shown
that the bre and daf-2 mutants, which are known to be resistant to
B. thuringiensis PFT (22) and other bacterial pathogens (33), re-
spectively, are as susceptible to B. thuringiensis DB27 as wild-type
worms are (31). These findings suggest that potentially novel
mechanisms are required to provide defense against this highly
virulent Bacillus strain.
Here, we report a genetic screen for B. thuringiensis DB27-
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resistant mutants ofC. elegans and show that a gene represented by
two alleles is identical to the nasp-1 gene C09H10.6. Further char-
acterization revealed that the nasp-1 mutant shows a reduced life
span and reduced fecundity and is RNA interference (RNAi) de-
ficient. Microarray analysis uncovered an unexpected enrichment
of dcr-1-regulated genes in nasp-1 mutants. We explored a poten-
tial role for dcr-1 in C. elegans innate immunity and show that
dcr-1 allele mutants deficient in microRNA (miRNA) processing,
but not those that are only deficient in RNAi, are resistant to B.
thuringiensis DB27. Transgenic expression of dcr-1 in nasp-1 mu-
tants can rescue the resistance phenotype of nasp-1 mutants. We
identified the collagen-encoding gene col-92 as one of the down-
stream effectors of nasp-1 and dcr-1. These findings describe
NASP-1 as a novel C. elegans innate immunity regulator and iden-
tify a previously unknown role for DCR-1 in the C. elegans anti-
bacterial immune response.
MATERIALS AND METHODS
Nematodes and bacterial strains. C. elegans strains were maintained on
nematode growth medium (NGM) agar plates with Escherichia coli OP50
as a food source. The following strains were kindly provided by the Cae-
norhabditis Genetics Center (University of Minnesota): wild-type Bristol
(N2), Hawaiian mapping strain (CB4856), DA453 eat-2(ad453), WM49
rde-4(ne301), WM27 rde-1(ne219), CB189 unc-32(e189), BB1 dcr-
1(ok247)/unc-32(e189) III, YY11 dcr-1(mg375), VC1138 drsh-1(ok369),
VC446 alg-1(gk214), BA1 fer-1(hc1), and BA15 fer-15(hc15). btr-1/
C09H10.9(tu439) and btr-1(tu440) mutant worms were generated in this
study and backcrossed to wild-type worms four times before analysis.
Double mutants were generated by using standard procedures (34). Ser-
ratia marcescens C2 was isolated from Reunion Island, S. aureus Newman
and P. aeruginosa PA14 were purchased from the Deutsche Sammlung
von Mikroorganismen und Zellkulturen, and B. thuringiensis DB27 was
isolated from dung beetles (31).
Genetic screen forB. thuringiensisDB27-resistant nematodes.After
ethyl methanesulfonate (EMS) mutagenesis (50 mM for 4 h at 20°C),
single parental (P0) mothers were separated onto NGM OP50 plates and
allowed to lay 10 to 30 eggs. F1 mothers were allowed to lay F2 progeny
that, upon reaching the L4 stage, were placed onto plates with pathogenic
B. thuringiensis DB27. After 24 h of incubation at 25°C, single worms that
survived pathogen exposure were transferred to NGM OP50 plates and
allowed to reproduce. These candidates were retested several times in
survival assay to confirm the resistance phenotype.
C. elegans killing assays. Each bacterium was grown overnight in a
shaking incubator at 30°C in Luria-Bertani (LB) broth, except S. aureus
and P. aeruginosa, which were grown at 37°C. A 100-l volume of the
culture was spread to the edges of a 6-cm NGM plate to prevent worms
from escaping and incubated overnight. Three to six independent repli-
cates of 20 adult worms per plate were exposed to pathogens and moni-
tored for survival. Survival assays were repeated multiple times and con-
ducted at 25°C. Nematodes were transferred once a day to fresh plates and
considered dead when they failed to respond to touch. We note that the
exact nature of the killing assay (inoculum size etc.) might have an influ-
ence on the quantitative killing results reported in this study.
Complementation test, mapping, sequencing, and rescue of tu439.
Complementation tests were performed by testing F1 progeny from the
crosses between btr-2(tu438) mutant males and dpy-5;tu439 or dpy-5;
tu440 mutant hermaphrodites. To test if tu439 and tu440 are allelic, F1
progeny from a cross between tu439 mutant males and dpy-5;tu440 mu-
tant hermaphrodites were tested. For mapping, the btr-1 mutant was
crossed to Hawaiian strain CB4856 and approximately 400 F2 cross prog-
eny were isolated and screened for B. thuringiensis DB27 resistance. DNA
was isolated from a total of 96 tu439-positive recombinant progeny and
used for restriction fragment length polymorphism (RFLP)–single-nucle-
otide polymorphism (SNP) mapping (35). SNP data from the most infor-
mative recombinants identified a 160-kb region on chromosome II be-
tween the markers F38A3 and F37H8. Whole-genome sequencing of btr-1
mutants revealed that both btr-1 alleles contain two identical mutations in
the mapping interval, which were found in the gene C09H10.6. For trans-
formation rescue, a 2.3-kb PCR fragment, covering upstream and down-
stream regions of the C09H10.6 transcript, was amplified from wild-type
genomic DNA and injected together with a sur-5::gfp plasmid as a coin-
jection marker into a btr-1 mutant as described elsewhere (36).
For dcr-1, dpy-5, and col-92 overexpression, respective transcripts with
presumptive regulatory regions were PCR amplified from wild-type
genomic DNA, purified, and used for injection together with the sur-5::gfp
plasmid as a coinjection marker. For intestine-specific expression, a
3.5-kb cpr-1 promoter fragment was amplified from wild-type DNA and
fused with the dcr-1 transcript by using Phusion High-Fidelity DNA poly-
merase (NEB) according to the manufacturer’s instructions. The resulting
construct was used for btr-1 microinjection. Reporter gene constructs for
gene expression analysis were created by the PCR fusion method as de-
scribed previously (37). A nasp-1::GFP (green fluorescent protein) trans-
lational reporter was obtained by PCR amplification of the nasp-1 tran-
script with the presumptive promoter region from wild-type genomic
DNA, which in the next step was PCR fused to GFP, which was amplified
from the pPD95.75 plasmid. A col-92 transcriptional reporter was gener-
ated in the same way, with the exception that only a 1.4-kb col-92 pro-
moter region was fused to GFP. The resulting constructs were purified and
used for injection together with the pRF4 plasmid (rol-6). Several inde-
pendent lines were obtained and tested for all of the transgenic experi-
ments described here.
Mutant identification by whole-genome sequencing. We sequenced
a genomic library of the btr-1(tu439) mutant on the Illumina Genome
Analyzer II platform and obtained 7,398,278 read pairs (2 100 bp). Raw
reads were aligned with theC. elegans genome assembly (WS235) by using
bwa (version 0.5.9-r16) (38). After the removal of duplicated reads to
exclude false variant calls due to PCR amplification biases, 98.8% of theC.
elegans assembly was covered by at least one read, with a genome-wide
mean coverage of 15. Variants were called by using SAMtools (version
0.1.18-r982:295) (39). In total, we identified 2,092 homozygous base sub-
stitutions with a SAMtools quality score of at least 20, of which six variants
were located within the 160-kb mapping interval on chromosome II. Fil-
tering for variants with a potential deleterious effect (nonsynonymous
substitution, premature stop codons, and mutations near splice sites)
could exclude three variants as intergenic and intronic, respectively. Two
of the remaining three nonsynonymous substitutions were found to affect
the nasp-1 gene (amino acid changes, L53S and D307N), and one substi-
tution at genomic position II:11069603, G to A (WS235), was found to
cause an S-to-F amino acid exchange in various alternative transcripts of
unc-53. A rescue experiment confirmed that mutations responsible for the
phenotype occurred in the nasp-1 gene.
Pumping rate measurement. Pharyngeal pumping was counted for 1
min starting on the first day of adulthood. Worms were placed on B.
thuringiensis DB27 plates at 25°C and left undisturbed for 3 h before
measurement. All worms remained on food during the period of obser-
vation. The eat-2(ad453) mutant, known to have low pumping, was used
as a control.
Brood size measurement. Brood size was determined by picking L4
worms (one per plate) and transferring them to fresh plates every 24 h
until egg laying ceased. The offspring were counted 2 days after the moth-
ers were removed from the plates. Ten worms were used per strain per
experiment, and experiments were repeated twice.
Life span assay. Life span assays were performed on NGM plates con-
taining 0.1-mg/ml 5=-fluorodeoxyuridine (FUDR) to prevent progeny
from hatching at 20°C. Plates were seeded with concentrated OP50 and
allowed to dry overnight. A synchronized population of L4 worms grown
on OP50 was placed onto the plates and scored every 48 h. For col-92RNAi
life span assays, NGM plates containing 50 g/ml carbenicillin, 1 mM
isopropyl--D-thiogalactoside (IPTG), and 0.1 mg/ml FUDR were seeded
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with E. coli HT115 expressing col-92 double-stranded RNA (dsRNA) (ex-
periment) or E. coli HT115 harboring the empty vector (control). A syn-
chronized population of L4 worms grown on col-92 RNAi bacteria or
vector-containing bacteria were placed onto the RNAi plates with FUDR
and scored every 48 h. Upon depletion of food, worms were transferred to
fresh plates. Worms were considered dead when no response to touch was
observed. Approximately 100 worms were used per strain per experiment,
and experiments were repeated twice.
RNAi. To generate specific gene knockdowns, we used RNAi by feed-
ing nematodes with E. coli expressing dsRNA that is homologous to a
target gene. E. coli harboring the empty vector was used as a control. E. coli
strain HT115 harboring the appropriate vector was grown in LB broth
containing 100 g/ml ampicillin at 37°C overnight. Bacteria were plated
onto NGM plates containing 50 g/ml carbenicillin and 1 mM IPTG and
allowed to grow overnight at 37°C. Three adult hermaphrodites were
placed on each RNAi plate and allowed to lay eggs. These eggs were grown
on RNAi plates for 3 days at 22°C to the adult stage before being trans-
ferred to plates with B. thuringiensis DB27 for pathogenicity assay. All of
the RNAi clones used in this study are part of the RNAi library obtained
from Source BioScience UK Limited (Nottingham, United Kingdom).
cdc-25 RNAi plates were prepared as described above. However, worms
were grown at 25°C to the adult stage. cdc-25.1 encodes a CDC25 phos-
phatase homolog that affects embryonic viability and is necessary for cell
proliferation in the germ line. In brief, gravid worms were laid on cdc-25.1
RNAi plates for 4 h and then transferred to similar plates for an additional
4 h of egg laying. After that, gravid hermaphrodites were removed and
eggs were left to hatch and grow in the presence of cdc-25.1 RNAi to
produce sterile worms. cdc-25 RNAi by injection was performed as de-
scribed below. For mom-2 RNAi, three adult hermaphrodites were placed
on mom-2 RNAi plates and allowed to lay eggs. These eggs were grown on
RNAi plates at 20°C to the adult stage. Single adults were subsequently
placed onto freshly prepared mom-2 RNAi plates and allowed to lay eggs
for 24 h and then removed from the plates. After 16 h, the total amounts of
eggs and hatched larvae were scored and viability was expressed as follows:
(number of hatched larvae/total number of eggs)  100. The mom-2
coinjection experiments were conducted at 20°C as described previously
(40).
dsRNA for injection experiments was prepared by in vitro transcrip-
tion. DNA templates were PCR amplified from plasmids corresponding to
the RNAi clones with T7 primers or PCR amplified from C. elegans
genomic DNA with gene-specific primers with attached T7 promoters in
case the gene is not present in the available RNAi library. PCR products
were used for dsRNA synthesis in a single reaction with the TranscriptAid
T7 high-yield transcription kit (Thermo Scientific). Concentrations of
dsRNAs were determined with a spectrophotometer, and the quality and
size of dsRNAs were assessed by gel electrophoresis. Young hermaphro-
dites were injected in the gonads with 300 to 600 ng/l of dsRNA of the
candidate gene. Given that dpy-5 RNAi produces a clear morphological
phenotype but has no effect on survival, dpy-5 dsRNA was used as a
positive control for injection and as a negative control in survival assays.
Adult F1 worms were used in the pathogen survival assay.
RNA collection for microarray experiments. Synchronized popula-
tions of wild-type and tu439 mutant C. elegans worms were obtained by
hypochlorite treatment and allowed to grow to the young adult stage on E.
coli OP50 at 20°C. Worms were exposed to B. thuringiensis DB27 for 4 h
and then picked into TRIzol reagent for RNA extraction. Four biological
replicates were collected for each experimental condition and the control
condition. For each biological replicate, about 200 young adult hermaph-
rodites were picked into 1 ml of TRIzol (Invitrogen) and total RNA was
extracted according to the manufacturer’s instructions and purified fur-
ther by phenol-chloroform-isoamyl alcohol precipitation. The RNA pel-
let was suspended in RNase-free water and assessed on a NanoDrop spec-
trophotometer for quantity and RNA quality.
Microarray experiments and data analysis. Oligonucleotide mi-
croarrays forC. elegans containing43,000 unique probes for20,000C.
elegans genes were obtained from Agilent Technologies (NCBI GEO ac-
cession number GPL10094). All experiments are in a two-color format,
where Cy5 and Cy3 dye-labeled cRNAs from experimental and control
samples are cohybridized on the same microarray. The four biological
replicates per experiment included two dye swap experiments to account
for differences in dye labeling. Experimental procedures and data analysis
were essentially the same as described before (41). Microarrays corre-
sponding to three of the four biological replicates passed the quality cri-
teria and were used in the final analysis. Genes with a false-discovery rate
(FDR)-corrected P value of 0.05 and an absolute fold change greater
than or equal to a cutoff of 1.5 on a log2 scale were called differentially
expressed.
Expression cluster enrichment analysis. The list of microarray ex-
pression profiles in which a given C. elegans gene is known to be differen-
tially expressed can be extracted from the Expression Cluster section of the
WormBase (42) gene summary page for each gene. We retrieved all of the
available expression clusters for C. elegans genes from the WormBase
website (www.wormbase.org) and used them to identify expression clus-
ters enriched in our expression profile, an approach that we have success-
fully used previously to analyze genome-wide trends in expression profiles
(11, 41). P values for expression cluster enrichment in each expression
profile were computed with a two-by-two Fisher exact test. An FDR-
corrected P value cutoff of 0.05 was used as the significance threshold.
qRT-PCR. Synchronized C. elegans worms at the L4 stage were ex-
posed to B. thuringiensis DB27 for 4 h before harvesting. Nematodes were
collected by washing plates with M9 buffer, and RNA was extracted with
TRIzol reagent. cDNA was synthesized with the SuperScript  kit (Invit-
rogen). Quantitative real-time PCR (qRT-PCR) was conducted with the
LightCycler 480 SYBR green  master kit (Roche) on a LightCycler 480
real-time PCR instrument (Roche) in a 96-well format. Relative fold
changes in transcripts were calculated by the comparative cycle threshold
(CT) method after normalization to snb-1, which has been used previously
in qRT-PCR studies of C. elegans innate immunity (43–45). CTs were
determined by the Roche LightCycler software. All samples were run in
triplicate. The sequences of the primers used are available upon request.
Statistical analysis. Kaplan-Meier nonparametric comparisons and a
log rank test were used for statistical analysis of C. elegans survival in the
presence of pathogens and for life span analysis. In each case, curves rep-
resent the combined data from at least three independent experiments.
Statistical analysis of the difference between two values was performed
with Student’s t test. Statistical significance was set at P 0.05.
Microarray data accession number. Raw and processed data from all
of the experiments described here are available under accession number
GSE43905 in the NCBI Gene Expression Omnibus database (http://www
.ncbi.nlm.nih.gov/geo/).
RESULTS
Forward genetic screen forB. thuringiensisDB27-resistant (btr)
mutants. B. thuringiensis DB27 was isolated from a dung beetle
(31) and was selected for detailed investigation because of its high
virulence for C. elegans. This strain is 100% lethal in just 16 h
under standard assay conditions (Fig. 1A). Our previous studies
indicated that all of the bre and daf-2 mutants tested were as sus-
ceptible to B. thuringiensis DB27 as wild-type worms are (31). In
contrast to the observed susceptibility of C. elegans, the second
model nematode organism, P. pacificus, is fully resistant to B. thu-
ringiensis DB27 (31). To uncover a potential resistance mecha-
nism and to better understand the specificity of B. thuringiensis
virulence for certain nematode species, we conducted a forward
genetic screen for mutants ofC. eleganswith strong resistance toB.
thuringiensis DB27. Specifically, we screened for mutants that
would extend C. elegans survival on monoxenic cultures of B. thu-
ringiensis DB27 by at least a factor of 3, in order to select for major
effectors. From 1,800,000 EMS-mutagenized gametes, we isolated
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three btr (B. thuringiensis-resistant) mutants that exhibited strong
resistance to B. thuringiensis-mediated killing (Fig. 1B). Comple-
mentation tests revealed that these mutants fall into two comple-
mentation groups (data not shown) with two alleles (tu439 and
tu440) of a locus provisionally named btr-1 and a single allele
(tu438) of a second locus called btr-2. Here we further characterize
btr-1.
btr-1(tu439) mutants are resistant to additional pathogens
and have a reduced life span. Considering that several pathogen-
resistant C. elegans mutants are resistant to multiple pathogens
(33), we exposed btr-1(tu439) mutant worms to additional patho-
gens to further characterize the specificity of the mutant. We
found that tu439 mutants exhibited stronger resistance to the
Gram-positive pathogen S. aureus than wild-type worms did (Fig.
1C). In contrast, tu439 mutants showed wild-type survival on the
Gram-negative pathogensP. aeruginosa and S.marcescens (Fig. 1D
and E). These results indicate that tu439 confers resistance to two,
but not all, of the pathogens tested.
To explore additional functions, we tested several physiologi-
cal parameters of tu439 mutant worms. First, we estimated the
pumping rate as an indirect measurement of bacterial uptake to
elucidate bacterial consumption. The pumping rate of the
tu439 mutant on DB27 is similar to that of the wild type,
whereas the control eat-2(ad453) mutant shows the expected
reduction of pumping in our assay system (Fig. 2A). Thus,
pharyngeal pumping is unaffected, suggesting that pathogen
consumption is not reduced in mutant worms. To rule out the
possibility that bacteria might persist in the intestines of wild-
type but not mutant worms, we fed worms with DB27 for 4 h,
which is sufficient to observe accumulation of bacteria in the
gut (see Fig. S1A in the supplemental material). We then
shifted the worms to OP50 for 2 h and measured the DB27
CFU. Neither the wild-type nor the mutant worms showed a
difference in their DB27 CFU counts after the shift to OP50,
suggesting that the persistence of DB27 is not extended in wild-
type worms (see Fig. S1B). Second, we observed that tu439
mutants exhibit reduced fertility (see Fig. S1C). A similar phe-
notype was also annotated for other pathogen-resistant mu-
FIG 1 Differences in the survival of wild-type and btr mutant worms upon exposure to different pathogenic bacteria. (A) C. elegans wild-type (wt) N2 is highly
susceptible toB. thuringiensis (BT) DB27, in contrast to standardE. coliOP50, which was used as a control (P 0.0001). (B) Survival of btrmutants on monoxenic
cultures of B. thuringiensis DB27. All alleles showed significantly (P  0.0001) enhanced survival compared to that of the wild type. (C) tu439 mutants show
increased resistance to S. aureus compared to that of the wild type (P 0.0001). (D, E) tu439 mutants are as susceptible as wild-type worms to P. aeruginosa (D,
P 0.05) and to S. marcescens (E, P 0.05). For survival curves, the numbers of live versus dead worms were scored over time. The number of worms alive (N
nematodes) is plotted as a function of time. The data shown are means the standard errors of the means. For each condition in the survival assay, 60 to 80 worms
(20 per plate) were used for each of multiple independent biological replicates.
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tants (46–48) and suggests that there is a tradeoff between re-
production and an elevated immune response. This raises the
possibility that tu439 confers increased resistance to B. thurin-
giensis DB27 because of diminished fecundity.
To elucidate this further, we assessed the survival of sterile
mutants exposed to B. thuringiensis DB27. First, we investigated
fecundity in combination with matricidal internal hatching of
eggs by comparing the survival of wild-type worms to that of fer-1
and fer-15 mutants (47). fer mutants have a germ line but do not
suffer from matricidal effects due to the lack of fertilization since
their sperm production is affected (49). Both fer mutants are as
susceptible to B. thuringiensis DB27 as wild-type worms are, sug-
gesting that matricidal hatching of eggs does not contribute to B.
thuringiensisDB27 killing and that increased resistance of tu439 to
DB27 is not due to a lack of matricide (Fig. 2B). This finding is
further supported by the fact that males are susceptible to DB27
(not shown).
In a second set of experiments, we used cdc-25 RNAi, which
also causes sterility. cdc-25 RNAi led to enhanced survival of wild-
type worms exposed to B. thuringiensis DB27 (Fig. 2C). However,
cdc-25 RNAi in a tu439 background resulted in a significant in-
crease in resistance to DB27 that was stronger than the resistance
of single tu439 mutant or wild-type cdc-25 RNAi worms (Fig. 2C).
The cumulative effect of the two mutations suggests that the un-
derlying molecular mechanisms are independent and that tu439-
mediated resistance to B. thuringiensis DB27 is not due simply to
reduced fecundity. Additionally, in contrast to sterile mutants, the
tu439 mutant is not resistant to S. marcescens and P. aeruginosa
(Fig. 1D and E). Finally, we measured the life span of tu439 mu-
tants, given that life span extension often correlates with increased
pathogen resistance in C. elegans (33, 47). Interestingly, we found
that tu439mutants fed onE. coliOP50 show a slight but significant
life span reduction in comparison to wild-type worms (Fig. 2D).
These results show a novel relationship between life span and im-
munity and suggest that tu439 mutant worm resistance to bacte-
rial infection is not a simple consequence of extended longevity.
Taken together, tu439 mutant worms are resistant to several
Gram-positive bacteria, have a reduced life span and fecundity,
and show that immunity can be mechanistically uncoupled from
aging.
btr-1 is identical to the C. elegans nasp-1 gene. To clone
tu439, we used RFLP-SNP mapping (35) and next-generation se-
quencing (50). In brief, we mapped btr-1 to an approximately
160-kb region on chromosome II between the markers F38A3 and
F37H8. Whole-genome sequencing of both alleles revealed muta-
tions in the C09H10.6 gene, which has been described as the C.
elegans homolog of the gene for human nuclear-autoantigenic-
sperm protein (nasp-1) (Fig. 3A). nasp-1 has previously been im-
plicated in C. elegans female development (51).
Interestingly, the two alleles appear to contain two identical
mutations, which might be due to the fact that they were derived
from a single mother. The first mutation is a T-to-C substitution
FIG 2 tu439 mutants exhibit increased resistance to DB27 independently of reduced fertility and longevity. (A) The pumping rate of tu439 mutants shows no
difference from that of the wild type (P 0.05). The control eat-2 mutant strain shows the expected lower pumping rate than that of the wild type (P 0.0001).
At least 10 worms were scored per strain. The data shown are means the standard errors of the means. (B) fer-1 and fer-15 mutants show no difference (P
0.05) from wild-type worms on a lawn ofB. thuringiensis (BT) DB27. The data shown are means the standard errors of the means. For each condition in survival
assays, 60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates. (C) Wild-type and tu439 nematodes were injected with
cdc-25 interfering dsRNA to obtain sterile worms or with control interfering dsRNA (see Materials and Methods) and exposed to DB27. cdc-25RNAi significantly
increases the resistance of wild-type [P 0.0001 for wt (vector) versus wt;cdc-25 worms] and tu439 mutant (P 0.0001 for tu439;control versus tu439;cdc-25
worms) worms. The survival of tu439;cdc-25 mutant worms is significantly higher (P 0.0001) than that of tu439 mutant or wt;cdc-25 worms alone. (D) The life
span of tu439 mutants is significantly (P 0.001) lower than that of wild-type worms on standard food (E. coli OP50). At least 100 worms were used per strain
per experiment, and each experiment was done twice. The data shown are means the standard errors of the means.
Iatsenko et al.












in the second exon of C. elegans nasp-1 resulting in a leucine-to-
serine substitution at amino acid position 53, whereas the second
mutation (a G-to-A change in exon 3) leads to a substitution from
aspartic acid to asparagine at amino acid position 307 (Fig. 3A).
To confirm that the resistance phenotype of tu439 is due to these
mutations in C09H10.6, we performed rescue and RNAi ex-
periments. First, transgenic expression of a wild-type copy of
C09H10.6 under the control of its endogenous promoter in the
tu439mutant background resulted in almost complete restoration
of wild-type susceptibility toB. thuringiensisDB27 (Fig. 3B) and S.
aureus (Fig. 3C). Additionally, transgenic expression of C09H10.6
partially rescued the diminished reproduction of the tu439 mu-
tant (not shown). Second, C09H10.6 RNAi increases nematode
resistance to B. thuringiensis DB27 (Fig. 3D) and S. aureus (Fig.
3E) in a way similar to that of tu439, providing additional evidence
that the mutant is allelic to C09H10.6. Also, we noticed thatnasp-1
RNAi worms have slower growth and less fecundity at 25°C than
vector-treated worms. The high conservation of the amino acids
that were mutated (see Fig. S2 in the supplemental material), es-
pecially D307, suggests that our nasp-1 mutant is a strong reduc-
tion-of-function allele. Also, the similarity between the nasp-1
RNAi and the mutant phenotype suggests that the isolated alleles
represent reduction-of-function rather than neomorphic muta-
tions. In summary, we conclude that btr-1(tu439) is identical to
the nasp-1-like gene C09H10.6. Following standard C. elegans no-
menclature rules, we rename btr-1 as nasp-1.
FIG 3 Identification of the tu439 allele. (A, top) Exon-intron structure of the C09H10.9 gene, adapted from WormBase (WS235), with the positions of mutations
indicated by arrows. Numbers indicate positions on chromosome where single-nucleotide mutations occurred. (A, bottom) Schematic domain structure of the
C09H10.9 protein. The black box shows the location of the TPR domain, which is not affected in either of the btr-1mutants. The dashed lines highlight the amino
acid sequences flanking the mutation sites. The black arrows show the position and type of amino acid substitution. (B) Rescue experiment. Transgenic
expression of nasp-1 under the control of its endogenous promoter restores wild-type (wt) susceptibility to B. thuringiensis (BT) DB27 to the tu439 mutant. (C)
tu439mutant resistance to S. aureus is rescued by transgenic expression of nasp-1 under the control of its endogenous promoter (P 0.05 for the wild type versus
the transgenic line). The data shown are means the standard errors of the means. (D) The survival on a lawn ofB. thuringiensisDB27 of wild-type worms grown
on dsRNA for C09H10.6, which corresponds to tu439, is significantly (P  0.0001) greater than that of worms grown on dsRNA as a vector control. (E) The
survival on a lawn of S. aureus of wild-type worms grown on dsRNA for C09H10.6, which corresponds to tu439, is significantly (P 0.001) greater than that of
worms grown on dsRNA as a vector control. The data shown are means the standard errors of the means. For each condition in survival assays, 60 to 80 worms
(20 per plate) were used for each of multiple independent biological replicates.
DCR-1/Dicer in C. elegans Innate Immunity












The p38 MAPK pathway is required for the nasp-1mutant’s
resistance. Next, we searched for potential interactions of nasp-1
with known pathogen response regulators to further explore its
biological role. First, we tested the p38 mitogen-activated protein
kinase (MAPK) pathway (52) by performing injection of pmk-1
dsRNA into a nasp-1 mutant background. After pmk-1 depletion,
the resistance of the nasp-1 mutant to B. thuringiensis DB27 is
completely abolished, even below the wild-type level (Fig. 4A).
Similarly, overactivation of PMK-1 by vph-1 RNAi (53) strongly
increased the survival of C. elegans on B. thuringiensis DB27 (Fig.
4A). In contrast, injection of dpy-5 as a control dsRNA had no
effect on the survival of wild-type and nasp-1 mutant worms, al-
though it did result in a dpy phenotype (Fig. 4A). Together, these
results suggest that the effects of pmk-1 and vhp-1 on survival are
gene specific and that nasp-1 potentially may function in parallel
with the p38 MAPK pathway. In contrast, RNAi of daf-16, another
C. elegans innate immunity regulator (33), had no effect on the
nasp-1 mutant’s resistance to B. thuringiensis DB27 (Fig. 4A), in-
dicating that nasp-1 does not confer resistance to B. thuringiensis
DB27 by acting through daf-16/FOXO. This result also provides
an additional argument that the nasp-1 mutant’s resistance is in-
dependent of reproduction, because increased pathogen resis-
tance of most of the sterile mutants requires daf-16 (47).
nasp-1mutants are deficient for RNAi by feeding.When per-
forming the RNAi experiments described above, we noticed that a
knockdown of genes by RNAi in a nasp-1 mutant background was
only possible by injection of dsRNA, suggesting that the nasp-1
mutant exhibits a sid phenotype (54). In contrast, RNAi by feed-
ing in the nasp-1 mutant background did not have the same effect
(Fig. 4B). Specifically, pmk-1 RNAi by feeding did not change the
nasp-1 mutant’s resistance phenotype, whereas pmk-1 RNAi by
injection abolished the nasp-1 mutant’s resistance to B. thurin-
giensis DB27 completely (Fig. 4B). Similarly, we observed that
dpy-5 RNAi by injection resulted in a dpy phenotype in a nasp-1
mutant background, whereas dpy-5RNAi by feeding did not (data
not shown). These observations provide first evidence that nasp-1
mutants might be defective in their RNAi response; however, they
do not exhibit a complete rde phenotype but rather show similar-
ity to sid mutants.
To further explore this phenotype, we fed nasp-1 mutants with
E. coli expressing dsRNA against mom-2, a gene essential for via-
bility (40, 55). Almost no viable progeny were obtained from wild-
FIG 4 nasp-1 mutant exhibits RNAi deficiency and requires PMK-1 but not DAF-16 for DB27 resistance. (A) pmk-1 knockdown upon RNAi by injection leads
to hypersusceptibility in wild-type (wt) worms (P 0.0001 for wt;dpy-5 versus wt;pmk-1 worms) and abolishes the resistance of the nasp-1 mutant (P 0.0001
for nasp-1;dpy-5 versus nasp-1;pmk-1 mutant worms) to B. thuringiensis (BT) DB27 below the level of wild-type survival (P 0.05 for nasp-1;pmk-1 versus wt
worms). daf-16 knockdown upon RNAi by injection has no effect on nasp-1 mutant (P 0.05 for nasp-1;dpy-5 versus nasp-1;daf-16 mutant worms) resistance
to B. thuringiensis DB27. vhp-1 RNAi significantly (P 0.0001) increases the survival of wild-type worms on a lawn of B. thuringiensis DB27 compared to control
dpy-5 RNAi, which was used as a positive control for injection and as a negative control in a survival assay (see Materials and Methods). (B) pmk-1 knockdown
upon RNAi by feeding has no effect on nasp-1-mediated resistance to B. thuringiensis DB27 (P  0.05), while pmk-1 knockdown upon RNAi by injection
abolishes the resistance of the nasp-1 mutant (P 0.0001). The data shown are means the standard errors of the means. For each condition in survival assays,
60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates. (C) nasp-1 mutant is RNAi deficient. Wild-type and nasp-1 and
rde-4 (positive control) mutant worms and nasp-1 rescuing line worms were fed E. coli expressing dsRNA of mom-2, which is essential for viability. Viability was
assessed as the proportion of hatched larvae relative to the total number of eggs laid. Both rde-4 and nasp-1 mutants show significantly (P  0.0001) higher
survival of progeny than the wild type, indicating that both mutants are resistant to RNAi-mediated mom-2 lethality. nasp-1 overexpression restores the
nasp-1(tu439) mutant’s susceptibility to mom-2-mediated lethality. The data shown are means the standard errors of the means. (D) Wild-type hermaphro-
dites were coinjected with each candidate dsRNA andmom-2dsRNA. rde-1RNAi was used as a positive control, whileunc-32RNAi was used as a negative control.
nasp-1 RNAi significantly increases F1 viability (P  0.0001) relative to that of the negative control or mom-2 RNAi alone. The data shown are means  the
standard errors of the means.
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type worms, whereas nearly 80% of the nasp-1 mutant progeny
survivedmom-2RNAi by feeding (Fig. 4C). Transgenic expression
of nasp-1 under the control of its endogenous promoter in the
tu439mutant background resulted in almost complete restoration
of the wild-type response to mom-2-mediated lethality. rde-4 mu-
tants, which are known to be RNAi deficient, were used as a con-
trol and showed nearly 100% viability (Fig. 4C). Additionally, we
coinjected wild-type worms with dsRNA ofmom-2 and/or dsRNA
of nasp-1 or control dsRNA and scored the viability of the prog-
eny. The survival of progeny indicates that RNAi against nasp-1
enables worms to overcome the lethality of mom-2 RNAi (Fig.
4D). Worms coinjected with dsRNA of a positive-control gene,
rde-1, showed 97% survival, indicating strong protection from
mom-2 lethality by rde-1RNAi. Coinjection with dsRNA ofunc-32
or other genes dispensable for RNAi resulted in a very low survival
rate. In contrast, coinjection of nasp-1 dsRNA significantly res-
cued the lethality caused by mom-2 dsRNA. Thus, in contrast to
RNAi mutants, such as rde-1 RNAi mutants, that are resistant to
RNAi independently of the delivery method (56), nasp-1 mutants
are still able to perform RNAi when dsRNA is injected into the
germ line. In this, they are similar to sid mutants (54), suggesting
that they function primarily in the uptake or spreading of dsRNA
rather than in modulation of the core RNAi machinery.
To provide further insight into this phenotype, we generated
transgenic worms expressing a nasp-1-encoded translational pro-
tein fusion with GFP to study the site of action of nasp-1. Interest-
ingly, expression was localized primarily in the pharynx (see Fig.
S3 in the supplemental material). Expression was seen in the meta-
corpus and terminal bulb of the pharynx with a clear intracellular
localization. Given that the pharynx is exposed to pathogens, this
observation further supports the idea that nasp-1 functions in in-
nate immunity; however, the link to the sid phenotype remains
unknown. Taken together, these results support the observation
that nasp-1 is required for a robust RNAi response.
The transcriptional response of nasp-1mutants toB. thurin-
giensis DB27 reveals a strong overlap with dcr-1 mutants. To
identify genes differentially regulated in nasp-1 mutants when
they are exposed to B. thuringiensis DB27, we used whole-genome
microarrays on an Agilent platform. Microarray analysis revealed
that differential expression in nasp-1 mutants mostly resulted in
downregulation (247 genes), whereas only 31 genes were more
strongly expressed in nasp-1 mutants than in wild-type worms
(see Data Set S1 in the supplemental material, FDR-corrected P
value of 0.05, fold change cutoff of 1.5 on a log2 scale). We
validated these results by selecting a total of 12 down- and upregu-
lated genes and confirmed their expression by qRT-PCR (Fig. 5A).
Interestingly, 58 of the 247 downregulated genes were previously
identified as genes that are induced by B. thuringiensis DB27, in
comparison to OP50, in wild-type worms (11) (Fig. 5B). These
results, together with the finding that most expression changes in
nasp-1 mutants result in transcriptional repression, suggest that
NASP-1 normally acts as an activator of transcription.
Surprisingly, further characterization of downregulated genes
in nasp-1 mutants revealed a highly significant overlap with genes
regulated by different components of the RNAi machinery (57),
such as rde-4, rde-3, and rrf-1 (see Fig. S4 in the supplemental
material). The most significant enrichment was found for genes
previously annotated as targets of the only C. elegans dicer gene,
dcr-1. Specifically, 116 of the 247 nasp-1-repressed genes were
previously identified as dcr-1-regulated genes (Fig. 5C). This
strong overlap is further supported by quantitative PCR experi-
ments showing that dcr-1 expression is itself reduced in nasp-1
mutants compared to that in the wild type (Fig. 5A). These find-
ings are consistent with the reduced life span and RNAi deficiency
of nasp-1 mutants (see above). Thus, an intriguing possibility is
that repression of DCR-1 function is responsible for the increased
pathogen resistance observed in nasp-1 mutants.
dcr-1 is involved in innate immunity through its role in
miRNA processing. The unexpected correlation between down-
regulated genes in nasp-1 and dcr-1 mutants encouraged us to
look for further interactions between these two loci. We hypoth-
esized that if reduced DCR-1 function in nasp-1 mutants were
responsible for their increased resistance to B. thuringiensis DB27,
dcr-1 mutants should also be more resistant to the pathogen. In-
deed, when we tested several dcr-1 alleles, we found that the mu-
tant for presumptive null allele dcr-1(ok247) showed greater sur-
vival on B. thuringiensis DB27 than the wild type (Fig. 6A). This is
unlikely to be due to altered reproduction because the dcr-
1(ok247) mutant is not resistant to S. marcescens (see Fig. S5A in
the supplemental material) and P. aeruginosa (see Fig. S5B) and
exhibits a reduced life span (58), in contrast to sterile mutants (59,
60). As the dcr-1(ok247) deletion allele was marked with a reces-
sive allele of unc-32 to facilitate the isolation of dcr-1(ok247) ho-
mozygous worms (57) and considering that the unc-32 mutant
was shown to have increased resistance to Erwinia carotovora and
Photorhabdus luminescens (8), we also tested the survival of unc-32
mutants onB. thuringiensisDB27 and found that they have a wild-
type response to the pathogen (Fig. 6A). Furthermore, transgenic
expression of dcr-1 in a dcr-1(ok247) mutant restored wild-type
susceptibility to B. thuringiensis DB27 (Fig. 6A). Together, these
findings indicate a novel role for dcr-1 in innate immunity to the
pathogen B. thuringiensis DB27.
Interestingly, the effect of dcr-1 on pathogen resistance is allele
specific. We found that survival on B. thuringiensis DB27 was un-
changed in the mutant with the activating dcr-1(mg375) allele
(Fig. 6A). The dcr-1(mg375) allele has an impaired helicase do-
main and small interfering RNA (siRNA) production and, conse-
quently, enhanced RNAi, whereas miRNA synthesis is intact (61).
To further test the idea that resistance to B. thuringiensis DB27 is
associated with altered miRNA processing, we investigated the
effects of the rde-4 and rde-1 mutations on pathogen survival.
rde-1 and rde-4 play a role in RNAi but not in miRNA processing
(57), and they were shown to produce a reduced life span but
normal survival on S. marcescens, although the immune response
is upregulated (57). Indeed, rde-1 and rde-4 mutants did not show
increased resistance toB. thuringiensisDB27 (Fig. 6B). In contrast,
mutants with changes in the drsh-1 and alg-1 genes, which are
involved in miRNA processing (62, 63), but not in RNAi, exhib-
ited increased resistance to B. thuringiensis DB27 (Fig. 6C). To
prove that the resistance of drsh-1 and alg-1 mutants is not due to
impaired germ line development and fertility, we rendered both
mutants sterile via cdc-25 RNAi and compared their survival to
that of control vector-treated worms. The survival of alg-1 mu-
tants was significantly increased after cdc-25 RNAi compared to
that of vector-treated alg-1 mutants and compared to wild-type
worms treated with either the empty vector or cdc-25 RNAi (Fig.
6D), indicating that alg-1 and cdc-25 mutants exhibit resistance
via distinct mechanisms and that alg-1-mediated resistance to B.
thuringiensis DB27 is not simply a consequence of altered fertility.
However, we did not observe any differences in survival between
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drsh-1 vector- and drsh-1 cdc-25 RNAi-treated worms (Fig. 6E),
suggesting that the increased resistance of drsh-1 mutants to B.
thuringiensis DB27 is indeed a secondary effect of sterility. Taken
together, these results suggest that the impairment of DCR-1
function in miRNA processing confers resistance to B. thuringien-
sis DB27. Furthermore, these data, together with the downregula-
tion of dcr-1 expression innasp-1mutants, support the conclusion
that the resistance of nasp-1 mutants is due to reduced DCR-1
activity.
nasp-1 acts through DCR-1/Dicer. The experiments de-
scribed above are consistent with the hypothesis that dcr-1 is ge-
netically downstream of nasp-1. This conclusion is further sup-
ported by previous expression profiling of dcr-1 mutants, which
did not show any change in the expression of nasp-1 in dcr-1
mutants (57). To further test this hypothesis, we investigated
whether overexpression of dcr-1 would abolish the increased re-
sistance of the nasp-1 mutant to B. thuringiensis DB27. Indeed,
dcr-1 overexpression under the control of its endogenous pro-
moter significantly reduced the survival of nasp-1 mutant worms
onB. thuringiensisDB27 (Fig. 6F). Additionally, dcr-1 overexpres-
sion restored the reduced life span of nasp-1 mutants (see Fig. S6
in the supplemental material). Given that C. elegans dcr-1 is ex-
pressed at high levels in the intestine (58), which is also the major
site of infection by ingested pathogens, we investigated whether
upregulation of dcr-1 specifically in the intestine could affect the
nasp-1 mutant’s pathogen resistance. When we overexpressed
dcr-1 under the control of the intestine-specific cpr-1 promoter,
we noticed a significant decrease in the nasp-1 mutant’s survival
on B. thuringiensis DB27 (Fig. 6F). Thus, the previously unknown
role of DCR-1 in C. elegans innate immunity is genetically down-
stream of nasp-1 and acts through the C. elegans intestine.
NASP-1 and Dicer resistance to S. aureus is due to impaired
fecundity. Considering that the nasp-1 mutant shows increased
resistance to S. aureus, we investigated whether it is also mediated
by the same mechanism that is employed in the defense against B.
thuringiensis DB27. Given that the nasp-1 mutant has reduced
fecundity, a common feature of S. aureus-resistant mutants (47),
we first tested if the nasp-1 mutant’s resistance to S. aureus de-
pends on reproduction. As shown in Fig. 7A, nasp-1 mutants in-
jected with cdc-25 interfering dsRNA survived S. aureus exposure
longer than control-injected worms. However, their survival was
similar to that of wild-type worms injected with cdc-25 interfering
dsRNA (Fig. 7A). Thus, nasp-1 mutants do not have an additive
effect with cdc-25 RNAi for S. aureus resistance, as is the case for B.
FIG 5 Transcriptional response of nasp-1 mutant worms to B. thuringiensis DB27 infection. (A) qRT-PCR confirmation of microarray results. Wild-type (wt)
and nasp-1 mutant worms were exposed to B. thuringiensis DB27 for 4 h and used for RNA isolation. The data shown are the average of two independent RNA
isolations. Each transcript was measured in triplicate and normalized to a control gene. Error bars show the standard errors of the means. (B) Venn diagram of
the genes downregulated in the nasp-1 mutant and upregulated in wild-type worms upon exposure to B. thuringiensis DB27 (11). The overlap is significant (P	
1.11E-15). (C) Venn diagram showing the overlap between genes downregulated in the nasp-1 mutant and genes upregulated in the dcr-1 mutant (47). The
overlap is significant (P	 3.70E-79).
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thuringiensis DB27 (Fig. 2C). These findings suggest that nasp-1
and cdc-25 RNAi increase resistance to S. aureus via the same
mechanism and the nasp-1 mutant’s resistance to S. aureus is very
likely due to partial sterility. In contrast, nasp-1 and cdc-25 RNAi
function in independent pathways for B. thuringiensis DB27 resis-
tance (Fig. 2).
This difference between S. aureus and B. thuringiensis DB27
was further explored by studying the allele specificity of Dicer
mutants. There was no allele specificity in terms of Dicer resis-
tance to S. aureus since both dcr-1(ok247) and dcr-1(mg375) mu-
tant worms were more resistant to S. aureus than wild-type worms
were (Fig. 7B). Also, dcr-1 mutant resistance can be rescued by
transgenic overexpression of dcr-1 under the control of its endog-
enous promoter (Fig. 7B), indicating that Dicer might play a role
in the C. elegans defense against S. aureus. Considering the repro-
ductive defects of dcr-1 mutants, which may contribute to in-
creased resistance to S. aureus, we used cdc-25 RNAi to sterilize
dcr-1(mg375) mutant worms. The survival of mg375 mutant
worms was greater than that of vector-treated worms but was not
significantly different from that of wild-type worms treated with
cdc-25 RNAi, indicating the absence of a cumulative effect of dcr-1
and cdc-25 (Fig. 7C). Thus, the dcr-1 mutant’s resistance to S.
aureus is due to diminished reproduction, as in the case of the
nasp-1 mutant. We also assessed the survival of RNAi- and
FIG 6 Repression of DCR-1 activity in miRNA processing but not in RNAi results in increased resistance to B. thuringiensis DB27. (A) The survival of different
dcr-1 alleles on a lawn of B. thuringiensis (BT) DB27 in comparison with wild-type (wt) and nasp-1 mutant worms. dcr-1(ok247) mutant worms are significantly
(P 0.0001) more resistant to B. thuringiensis DB27 than wild-type worms are. dcr-1(mg375) mutant worms show wild-type susceptibility to the pathogen (P
0.05). Transgenic expression of dcr-1 rescues the increased resistance of the dcr-1(ok247) mutant to B. thuringiensis DB27. (B) RNAi-defective rde-4(ne301) and
rde-1(ne219) mutants show survival comparable to that of wild-type worms (P 0.05) upon exposure to B. thuringiensis DB27. (C) Survival of miRNA-deficient
mutants upon exposure to B. thuringiensis DB27. alg-1(gk214) and drsh-1(ok369) mutants show resistance to DB27 greater than that of wild-type worms (P
0.0001). (D, E) Wild-type, alg-1 mutant (D), and drsh-1 mutant (E) nematodes were fed with cdc-25 RNAi vector to obtain sterile worms or with empty RNAi
vector and exposed to DB27. cdc-25 RNAi significantly increases the resistance of wild-type (P  0.0001 for wt;vector versus wt;cdc-25 worms) and alg-1 (D)
(P 	 0.002 for alg-1;vector versus alg-1;cdc-25) worms but not drsh-1 mutants (E) (P  0.05 for drsh-1;vector versus drsh-1;cdc-25 worms). The survival of
alg-1;cdc-25 mutant worms is significantly different (P 0.05) from that of wt;cdc-25 worms. The data shown are means the standard errors of the means. (F)
Transgenic overexpression of dcr-1 abolishes the resistance of the nasp-1 mutant to B. thuringiensis DB27. The resistance of nasp-1 mutants with transgenically
expressed dcr-1 under the control of its endogenous promoter (pdcr-1) or an intestine-specific promoter (pcpr-1) is significantly lower than that of nasp-1
mutants (P 0.0001). For each condition in survival assays, 60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates. The
data shown are means the standard errors of the means.
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miRNA-deficient mutants on S. aureus. Both rde-1 and rde-4 mu-
tants showed a wild-type response to S. aureus (Fig. 7D). The alg-1
mutant, which has increased survival on B. thuringiensis DB27,
exhibited survival similar to that of the wild type on S. aureus (Fig.
7D), while only the drsh-1 mutant was more resistant to S. aureus
infection (Fig. 7D). However, as in the case of B. thuringiensis
DB27, the increased resistance seen is the consequence of sterility
since cdc-25 RNAi did not further increase the survival of drsh-1
mutants (Fig. 7E). Taken together, these results show that the
nasp-1 mutant’s resistance to S. aureus is very likely due to im-
paired fecundity and at this stage it is impossible to disconnect
immune and reproductive mechanisms that confer the nasp-1
mutant’s resistance to S. aureus.
The collagen gene col-92 acts downstreamofnasp-1 and con-
fers resistance toDB27. Finally, we wanted to uncover the molec-
ular mechanisms of nasp-1- and dcr-1-mediated resistance to B.
thuringiensis DB27. For this, we hypothesized that the repression
of dcr-1 activity in nasp-1 mutants leads to overactivation of effec-
FIG 7 nasp-1- and dcr-1-mediated resistance to S. aureus is due to partial sterility. (A) Wild-type (wt) and nasp-1 mutant nematodes were injected with cdc-25
interfering dsRNA to obtain sterile worms or with control dsRNA (see Materials and Methods) and exposed to S. aureus. cdc-25 RNAi significantly increases the
resistance of wild-type (P 0.0001 for wt;vector versus wt;cdc-25worms) andnasp-1mutant (P 0.0001 fornasp-1;control versusnasp-1;cdc-25worms) worms.
The survival of nasp-1;cdc-25 mutant worms is not significantly different (P 0.05) from wt;cdc-25 worms. The data shown are means the standard errors of
the means. (B) Both dcr-1mutants ok247 andmg375 grown at 25°C to induce sterility exhibit increased resistance to S. aureus (P 0.0001 for ok247mutant versus
wt worms; P 0.001 for mg375 mutant versus wt worms), which can be rescued by transgenic expression of dcr-1. The ok247 and mg375 mutants do not differ
in the level of resistance (P 0.05). The data shown are means the standard errors of the means. (C) Wild-type and dcr-1(mg375) mutant nematodes were fed
with cdc-25 RNAi vector to obtain sterile worms or with empty RNAi vector (see Materials and Methods) and exposed to S. aureus. cdc-25 RNAi significantly
increases the resistance of wild-type (P  0.0001 for wt;vector versus wt;cdc-25 worms) and mg375 (P 	 0.018 for mg375;vector versus mg375;cdc-25 mutant
worms) worms. The survival of mg375;cdc-25 mutant worms is not significantly different (P  0.05) from that of wt;cdc-25 worms. The data shown are
means  the standard errors of the means. (D) Survival of wild-type worms and RNAi- and miRNA-deficient mutants upon exposure to S. aureus. Only
drsh-1(ok369) mutant worms showed greater S. aureus resistance than wild-type worms (P 0.0001). The data shown are means the standard errors of the
means. (E) Wild-type and drsh-1 mutant nematodes were fed with cdc-25 RNAi vector to obtain sterile worms or with empty RNAi vector and exposed to S.
aureus. cdc-25 RNAi significantly increases the resistance of wild-type (P  0.0001 wt;vector versus wt;cdc-25 worms) but not drsh-1 mutant (P  0.05
drsh-1;vector versus drsh-1;cdc-25 mutant worms) worms. The survival of drsh-1;cdc-25 mutant worms is not significantly different (P  0.05) from that of
wt;cdc-25 worms. For each condition in survival assays, 60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates. The data
shown are means the standard errors of the means.
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tor genes, which make C. elegans more resistant to infection. Con-
sistent with this idea, we found that several B. thuringiensis DB27-
responsive genes are more strongly expressed in nasp-1 and dcr-1
mutants than in the wild type (Fig. 8A). To test this hypothesis
further, we used RNAi to knock down nasp-1-upregulated genes
individually (see Data Set S1 in the supplemental material) in the
nasp-1mutant background. While the knockdown of the majority
of these genes resulted in no obvious effect on nasp-1-mediated
resistance (see Fig. S7 in the supplemental material), col-92 RNAi
produced significant suppression of nasp-1-mediated resistance
to DB27 (Fig. 8B; see Fig. S7) and S. aureus (Fig. 8C). Furthermore,
knockdown of col-92 in wild-type worms makes them hypersus-
ceptible to B. thuringiensis DB27 (Fig. 8D), S. aureus, and P.
aeruginosa (see Fig. S8A and B) but not to S. marcescens (see Fig.
S8C). However, the life span of col-92 RNAi worms was not af-
fected (see Fig. S8D), suggesting that its hypersusceptibility to bac-
terial infection is not a result of impaired fitness. In contrast,
col-92 overexpression under the control of its endogenous pro-
moter increases resistance toB. thuringiensisDB27 (Fig. 8E) and S.
aureus (see Fig. S8E) infections. At the same time, overexpression
of dpy-5, used as a control, resulted in no obvious effects on resis-
tance to B. thuringiensis DB27 (Fig. 8E) and S. aureus (see Fig.
S8E). Moreover, dpy-5 RNAi and col-93 RNAi had no effect on C.
elegans survival upon exposure to B. thuringiensis DB27, indicat-
ing that the effect of col-92 is specific and is unlikely to be due only
to simple alteration of cuticle structure.
To shed more light on the immune function of col-92, we stud-
ied the expression of the gene. It should be noted that COL-92 is a
FIG 8 Collagen gene col-92 acts downstream of nasp-1 and is required for resistance to B. thuringiensis (BT) DB27. (A) Some of the DB27 response transcripts
(selected from reference 11) show high expression in dcr-1 mutant worms as determined by qRT-PCR. The data shown are averages of two independent RNA
isolations. Each transcript was measured in triplicate and normalized to a control gene. Error bars show the standard errors of the means. (B) Injection of col-92
interfering dsRNA significantly (P  0.001) suppresses the nasp-1 mutant’s resistance to B. thuringiensis DB27 compared to the injection of a control gene
(dpy-5). The data shown are means the standard errors of the means. (C) Injection of col-92 interfering dsRNA significantly (P	 0.021) decreases the nasp-1
mutant’s resistance to S. aureus compared to the injection of a control gene (dpy-5). The data shown are means the standard errors of the means. (D) RNAi
knockdown of col-92 increases the susceptibility of wild-type (wt) worms toB. thuringiensisDB27 infection (P 0.01). The data shown are means the standard
errors of the means. (E) Transgenic expression of col-92 but not of dpy-5 significantly (P 0.02) increases the survival of worms exposed toB. thuringiensisDB27.
The data shown are means  the standard errors of the means. (F) Mechanism by which nasp-1 may regulate the innate immune response to B. thuringiensis
DB27.
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member of a nematode-specific family of collagens, characterized
by a cuticle collagen N-terminal domain. Transgenic lines harbor-
ing a col-92–GFP transcriptional fusion construct showed that the
gene is expressed predominantly in the hypodermis (see Fig. S9 in
the supplemental material). Therefore, although col-92 is a down-
stream target of NASP-1, its immune function awaits further
characterization and might be associated with cuticle. Thus, the
previously uncharacterized collagen gene col-92 plays a pivotal
role in the C. elegans defense against bacterial infection and rep-
resents a downstream target of NASP-1 and DCR-1.
DISCUSSION
In this study, we isolated a B. thuringiensis DB27-resistant mutant
in C. elegans that we showed to be identical to nasp-1, a gene that
has previously been implicated in female development (51). Both
nasp-1 alleles are reduction-of-function but not null alleles. Fur-
ther characterization of nasp-1 helped to discover a previously
unknown function of dcr-1/Dicer in the immune response of C.
elegans. Mammalian NASP1 is a tetratricopeptide (TPR) repeat
domain-containing H1 linker histone binding protein that is part
of a multichaperone complex implicated in nucleosome remodel-
ing (64, 65). NASP1 is highly expressed in dividing cells and is
required for normal cell cycle progression (65). A role for C. el-
egans nasp-1 in chromatin remodeling is supported by its interac-
tions with a variety of chromatin-remodeling proteins like linker
H1 histones and histone deacetylase (51). We hypothesize that
nasp-1might regulate the pathogen response ofC. elegans via tran-
scription and chromatin-remodeling mechanisms. Strikingly, it
was shown that changes in NASP1 expression lead to the misregu-
lation of a variety of genes in HeLa cells, including genes involved
in the immune responses (66).
The RNAi deficiency of C. elegans nasp-1 is similar to that of
other chromatin-remodeling genes (40) and provided the entry
point for the discovery of the function of dcr-1 in C. elegans innate
immunity, the most unexpected finding of this study. DCR-1 is an
RNase  endoribonuclease whose primary function is the cleav-
age of dsRNA into smaller fragments that mediate RNAi (67).
DCR-1 is required for miRNA processing and the synthesis of
endo-siRNAs implicated in gene silencing and epigenetic regula-
tion (67–69). Previous studies have shown a role for DCR-1 and
the RNAi machinery in the C. elegans response to viral infections
(14, 70). However, our results point toward a broader function of
Dicer in innate immunity. To our knowledge, this study is the first
to show a direct role for DCR-1 in antibacterial immunity. Results
obtained by using different mutant alleles of C. elegans dcr-1 sup-
port the conclusion that its function in pathogen defense is medi-
ated primarily by impaired miRNA biogenesis. Further evidence
for this conclusion comes from the analysis of other genes that
allow discrimination between miRNA processing and RNAi. Con-
sistent with our conclusion is a recent report showing that miRNA
activity in the C. elegans intestine is largely dedicated to attenuat-
ing the activity of pathogen response genes (48). Specifically, Kud-
low et al. (48) have shown that ain-1 mutants, which have altered
miRNA-induced silencing complex activity, are more resistant to
P. aeruginosa than wild-type worms are. Additionally, those au-
thors were able to identify specific miRNA families that are in-
volved in damping of the immune response in the absence of
infection. Together, these findings suggest that intestinal miRNAs
act as negative regulators of infection response genes. However,
we have been unable to identify a miRNA or siRNA that is likely to
be a part of the mechanisms of nasp-1-mediated resistance to B.
thuringiensis DB27. Such studies might be complicated by the fact
that redundancy among small RNAs is a well-known phenome-
non in C. elegans.
The increased resistance of dcr-1 mutants to B. thuringiensis
DB27 might be due to the upregulation of pathogen response
genes. Indeed, our RT-PCR experiment showed induction of
some of the B. thuringiensis DB27-responsive genes in dcr-1 mu-
tants (Fig. 8A), indicating that DCR-1 may function as a suppres-
sor of the C. elegans immune response to B. thuringiensis DB27 via
suppression of miRNA synthesis. By using a reverse genetic ap-
proach, we found that one of the nasp-1-upregulated genes,
namely, col-92, is an important determinant of the nasp-1 mu-
tant’s resistance that acts downstream of nasp-1 and dcr-1. Colla-
gens are differentially expressed in response to a variety of mi-
crobes (8, 71), suggesting that they may represent an essential part
of the immune response. Nematodes, including C. elegans, are
known for the unusually high number of collagens encoded in
their genomes, and collagens have been implicated in life span and
immunity (71–74). A potential role for collagens in the immune
response might be in part responsible for the high number of
nematode collagens, although direct proof of this assumption is
hard to provide, even in the age of reverse genetics. One phenom-
enon that might hinder the identification of specific functions of
collagens is redundancy, which is often seen among structurally
related genes (73).
Our findings on the role of DCR-1 in C. elegans innate immu-
nity strongly correlate with the identification of Dicer as a regula-
tor of the mammalian immune response. Tang and coworkers
found that the inhibition of Dicer in human cells upregulates ma-
jor histocompatibility complex class -related molecules A and B,
which are innate immune system ligands for the NKG2D receptor
expressed by natural killer cells (75). Those authors proposed fur-
ther that a Dicer knockdown is indirectly linked to human innate
immunity via the DNA damaging pathway. Whether a similar
DNA-damaging pathway is involved in the upregulation of the C.
elegans innate immune response awaits further analysis. Addition-
ally, various miRNAs have been implicated in the regulation of
diverse aspects of human innate immunity (76), including direct
microbial killing. For example, miR-223-deficient neutrophils
were shown to kill Candida albicans more effectively then wild-
type cells do (77). A role for miRNAs in the human immune sys-
tem is further supported by evidence that many immunological
diseases are caused by alteration of miRNA function (76). There-
fore, Dicer and miRNAs might play a conserved role as negative
regulators in immunity.
Although alterations of dcr-1 or miRNA functions are benefi-
cial to C. elegans under pathogenic conditions because of immune
response activation, this can be deleterious under normal growth
conditions. Consistent with this, nasp-1mutants showed compro-
mised reproduction, like many other pathogen-resistant mutants
(47), indicating that the immune system might compete with the
reproductive system for resources. Generally, chronic immune
activation has been linked to several pathological disorders, like
inflammatory bowel disease in humans (78). Therefore, it is cru-
cial to any organism to have mechanisms of innate immune sup-
pression in the absence of pathogens.
On the basis of our results, we propose the following mecha-
nism for the function of nasp-1 in the regulation of C. elegans
innate immunity (Fig. 8F). First, nasp-1 is a regulator of dcr-1. In
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nasp-1 mutants, dcr-1 function is repressed because of chromatin
remodeling or related mechanisms, which leads to, besides RNAi
deficiency, the inhibition of dcr-1-mediated miRNA processing.
Consequently, certain miRNAs are not processed and, in turn,
target genes, including col-92, are more strongly expressed than
normal. As a consequence, mutant worms are more resistant to B.
thuringiensis DB27 infection. Additionally, nasp-1, dcr-1, and
drsh-1 mutants exhibit increased resistance to S. aureus as a sec-
ondary consequence of altered reproduction likely because of
germ line defects. In general, germ line defects and fecundity
might play a role in the observed resistance phenotypes of nasp-1
and dcr-1 mutants. It is important to note, however, that nasp-1
dcr-1 double mutants with cdc-25 RNAi gave different results for
resistance to B. thuringiensis DB27 and S. aureus, respectively.
These findings indicate complex interactions between fecundity
and nematode immunity.
Given the comparative framework of our work, what about the
specificity of nasp-1 and the resistance of P. pacificus to B. thurin-
giensis DB27? While nasp-1 is clearly conserved in sequence, the
amino acid positions that are changed in the two C. elegans nasp-1
mutants are not. It is therefore possible that the exact molecular
mechanisms of nasp-1 and its role in nematode immunity did
change during the course of evolution. More generally, our paral-
lel work on innate immunity in P. pacificus has recently revealed
that more general anatomical and physiological parameters are in
part responsible for the observed differences between the two spe-
cies. P. pacificus is not equipped with a grinder, as is typical of
members of the family Diplogastridae, and so does not lyse its
bacterial food in the pharynx. P. pacificus mutants hypersuscepti-
ble to bacterial pathogens are often Unc mutants with an abnor-
mal defecation cycle, indicating that the regulation of the defeca-
tion cycle is crucial for innate immunity (32). Together, this
comparative work on innate nematode immunity points toward
the correlated action of anatomical, physiological, and molecular
mechanisms that control nematode-bacterial interactions and
regulate the evolution of innate nematode immunity.
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